rhenium has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Cheng, Z; Jurisson, SS; Miao, Y; Owen, NK; Quinn, TP | 1 |
Cantorias, MV; Carmack, TL; Cutler, CS; Figueroa, SD; Hoffman, TJ; Lever, JR; Quinn, TP; Watkinson, LD | 1 |
2 other study(ies) available for rhenium and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Article | Year |
---|---|
Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues.
Topics: alpha-MSH; Animals; Binding, Competitive; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Isotope Labeling; Melanoma; Mice; Mice, Inbred C57BL; Organometallic Compounds; Peptides, Cyclic; Radiopharmaceuticals; Rhenium; Tissue Distribution; Tumor Cells, Cultured | 2002 |
Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors.
Topics: Acetic Acid; Animals; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cyclization; Female; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Melanocyte-Stimulating Hormones; Melanoma; Mice; Mice, Inbred C57BL; Microwaves; Positron-Emission Tomography; Receptor, Melanocortin, Type 1; Rhenium; Staining and Labeling; Substrate Specificity; Tissue Distribution | 2009 |